Europe Clinical Trials Market 2022-2031 by Product Category (Drugs, Devices, Procedures), Phase (I, II, III, IV), Design (Interventional, Observational, Expanded Access), Service Type (Site Identification, Lab Services, Supply & Logistic, Decentralized Services), Indication (Oncology, Infectious Diseases, Cardiology, Obesity, Diabetes, Neurology), End User, and Country: Trend Forecast and Growth Opportunity

April 2023 | 186 pages | ID: EB864752658EEN
GMD Research

Abstracts

Europe clinical trials market was valued at valued at $10,939.1 million in 2022 and will grow by 6.4% annually over 2022-2031, driven by the increasing number of clinical trials and increase in demand for novel therapies, rising prevalence on chronic diseases such as cancer and diabetes, the outbreak of tropical and infectious diseases such as COVID-19, and the increase in government initiatives and R&D investments.

Highlighted with 99 tables and 79 figures, this 186-page report “Europe Clinical Trials Market 2022-2031 by Product Category (Drugs, Devices, Procedures), Phase (I, II, III, IV), Design (Interventional, Observational, Expanded Access), Service Type (Site Identification, Lab Services, Supply & Logistic, Decentralized Services), Indication (Oncology, Infectious Diseases, Cardiology, Obesity, Diabetes, Neurology), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe clinical trials market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2021-2022 and provides forecast from 2023 till 2031 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe clinical trials market in every aspect of the classification from perspectives of Product Category, Phase, Design, Service Type, Indication, End User, and Country.

Based on Product Category, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.

• Trials of Drugs
• Small Molecule Drugs
• Vaccines
• Cell & Gene Therapy
• Other Drugs
• Trials of Devices
• Trials of Procedures

Based on Phase, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.

• Phase I
• Phase II
• Phase III
• Phase IV

By Design, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.

• Interventional Studies
• Randomized Control Trial
• Adaptive Clinical Trial
• Non-randomized Control Trial
• Observational Studies
• Cohort Study
• Case Control Study
• Cross Sectional Study
• Ecological Study
• Expanded Access Trials

By Service Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.

• Protocol Designing
• Site Identification
• Patient Recruitment
• Laboratory Services
• Bioanalytical Testing Services
• Clinical Trial Data Management Services
• Clinical Trial Supply & Logistic Services
• Decentralized Clinical Trial Services
• Medical Device Testing Services
• Other Clinical Trial Services

By Indication, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.

• Oncology
• Infectious Diseases
• Cardiology
• Obesity
• Diabetes
• Neurology
• Immunology
• Pain Management
• Other Indications

By End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.

• Pharmaceutical and Biotechnological Companies
• Clinical Research Organizations
• Clinical Testing Laboratories
• Other End Users

Geographically, the following national/local markets are fully investigated:

• Germany
• UK
• France
• Spain
• Italy
• Russia
• Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)

For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2031. The breakdown of each national market by Phase, Design, and Indication over the forecast years are also included.

The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

Accell Clinical Research LLC

Charles River Laboratories

ClinDatrix Inc

Clinipace

Eli Lilly and Company

F. Hoffmann-La Roche Ltd.

ICON PLC

IQVIA Holdings, Inc.

Laboratory Corporation of America (Covance Inc.)

Novo Nordisk AS

PAREXEL International Corporation

Pfizer Inc.

Pharmaceutical Product Development LLC

PhlexEurope

PRA Health Sciences

Sanofi SA

SGS SA (SGS Life Sciences)

Syneos Health Inc.

Wuxi AppTec Inc.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Contents

1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
  2.1.1 Impact of COVID-19 on World Economy
  2.1.2 Impact of COVID-19 on the Market
  2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF EUROPE MARKET BY PRODUCT CATEGORY

3.1 Market Overview by Product Category
3.2 Trials of Drugs
  3.2.1 Small Molecule Drugs
  3.2.2 Vaccines
  3.2.3 Cell & Gene Therapy
  3.2.4 Other Drugs
3.3 Trials of Devices
3.4 Trials of Procedures

4 SEGMENTATION OF EUROPE MARKET BY PHASE

4.1 Market Overview by Phase
4.2 Phase I
4.3 Phase II
4.4 Phase III
4.5 Phase IV

5 SEGMENTATION OF EUROPE MARKET BY DESIGN

5.1 Market Overview by Design
5.2 Interventional Studies
  5.2.1 Randomized Control Trial
  5.2.2 Adaptive Clinical Trial
  5.2.3 Non-randomized Control Trial
5.3 Observational Studies
  5.3.1 Cohort Study
  5.3.2 Case Control Study
  5.3.3 Cross Sectional Study
  5.3.4 Ecological Study
5.4 Expanded Access Trials

6 SEGMENTATION OF EUROPE MARKET BY SERVICE TYPE

6.1 Market Overview by Service Type
6.2 Protocol Designing
6.3 Site Identification
6.4 Patient Recruitment
6.5 Laboratory Services
6.6 Bioanalytical Testing Services
6.7 Clinical Trial Data Management Services
6.8 Clinical Trial Supply & Logistic Services
6.9 Decentralized Clinical Trial Services
6.10 Medical Device Testing Services
6.11 Other Clinical Trial Services

7 SEGMENTATION OF EUROPE MARKET BY INDICATION

7.1 Market Overview by Indication
7.2 Oncology
7.3 Infectious Diseases
7.4 Cardiology
7.5 Obesity
7.6 Diabetes
7.7 Neurology
7.8 Immunology
7.9 Pain Management
7.10 Other Indications

8 SEGMENTATION OF EUROPE MARKET BY END USER

8.1 Market Overview by End User
8.2 Pharmaceutical and Biotechnological Companies
8.3 Clinical Research Organizations
8.4 Clinical Testing Laboratories
8.5 Other End Users

9 EUROPEAN MARKET 2021-2031 BY COUNTRY

9.1 Overview of European Market
9.2 Germany
9.3 U.K.
9.4 France
9.5 Spain
9.6 Italy
9.7 Russia
9.8 Rest of European Market

10 COMPETITIVE LANDSCAPE

10.1 Overview of Key Vendors
10.2 New Product Launch, Partnership, Investment, and M&A
10.3 Company Profiles
Accell Clinical Research LLC
Charles River Laboratories
ClinDatrix Inc
Clinipace
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
ICON PLC
IQVIA Holdings, Inc.
Laboratory Corporation of America (Covance Inc.)
Novo Nordisk AS
PAREXEL International Corporation
Pfizer Inc.
Pharmaceutical Product Development LLC
Phlexglobal
PRA Health Sciences
Sanofi SA
SGS SA (SGS Life Sciences)
Syneos Health Inc.
Wuxi AppTec Inc.
RELATED REPORTS

List Of Tables

LIST OF TABLES:

Table 1. Snapshot of Europe Clinical Trials Market in Balanced Perspective, 2022-2031
Table 2. Total Number of Registered Clinical Studies Worldwide, 2010-2021
Table 3. World Economic Outlook, 2021-2031
Table 4. World Economic Outlook, 2021-2023
Table 5. Scenarios for Economic Impact of Ukraine Crisis
Table 6. World Health Spending by Region, $ bn, 2013-2020
Table 7. Main Product Trends and Market Opportunities in Europe Clinical Trials Market
Table 8. Europe Clinical Trials Market by Product Category, 2021-2031, $ mn
Table 9. Europe Clinical Trials Market: Trials of Drugs by Drug Type, 2021-2031, $ mn
Table 10. Europe Clinical Trials Market by Phase, 2021-2031, $ mn
Table 11. Europe Clinical Trials Market by Design, 2021-2031, $ mn
Table 12. Europe Clinical Trials Market: Interventional Studies by Segment, 2021-2031, $ mn
Table 13. Europe Clinical Trials Market: Observational Studies by Segment, 2021-2031, $ mn
Table 14. Europe Clinical Trials Market by Service Type, 2021-2031, $ mn
Table 15. Europe Clinical Trials Market by Indication, 2021-2031, $ mn
Table 16. Europe Clinical Trials Market by End User, 2021-2031, $ mn
Table 17. Europe Clinical Trials Market by Country, 2021-2031, $ mn
Table 18. Germany Clinical Trials Market by Phase, 2021-2031, $ mn
Table 19. Germany Clinical Trials Market by Design, 2021-2031, $ mn
Table 20. Germany Clinical Trials Market by Indication, 2021-2031, $ mn
Table 21. U.K. Clinical Trials Market by Phase, 2021-2031, $ mn
Table 22. U.K. Clinical Trials Market by Design, 2021-2031, $ mn
Table 23. U.K. Clinical Trials Market by Indication, 2021-2031, $ mn
Table 24. France Clinical Trials Market by Phase, 2021-2031, $ mn
Table 25. France Clinical Trials Market by Design, 2021-2031, $ mn
Table 26. France Clinical Trials Market by Indication, 2021-2031, $ mn
Table 27. Spain Clinical Trials Market by Phase, 2021-2031, $ mn
Table 28. Spain Clinical Trials Market by Design, 2021-2031, $ mn
Table 29. Spain Clinical Trials Market by Indication, 2021-2031, $ mn
Table 30. Italy Clinical Trials Market by Phase, 2021-2031, $ mn
Table 31. Italy Clinical Trials Market by Design, 2021-2031, $ mn
Table 32. Italy Clinical Trials Market by Indication, 2021-2031, $ mn
Table 33. Russia Clinical Trials Market by Phase, 2021-2031, $ mn
Table 34. Russia Clinical Trials Market by Design, 2021-2031, $ mn
Table 35. Russia Clinical Trials Market by Indication, 2021-2031, $ mn
Table 36. Clinical Trials Market in Rest of Europe by Country, 2021-2031, $ mn
Table 37. Percentage of Registered Studies by Location (as of February 24, 2022)
Table 38. Percentage of Recruiting Studies by Location (as of February 24, 2022)
Table 39. Accell Clinical Research LLC: Company Snapshot
Table 40. Accell Clinical Research LLC: Business Segmentation
Table 41. Accell Clinical Research LLC: Product Portfolio
Table 42. Charles River Laboratories: Company Snapshot
Table 43. Charles River Laboratories: Product Portfolio
Table 44. Charles River Laboratories: Breakdown of Revenue by Division
Table 45. Charles River Laboratories: Breakdown of Revenue by Region
Table 46. ClinDatrix Inc: Company Snapshot
Table 47. Clinipace: Company Snapshot
Table 48. Clinipace: Product Portfolio
Table 49. Eli Lilly and Company: Company Snapshot
Table 50. Eli Lilly and Company: Pharmaceutical Brands
Table 51. Eli Lilly and Company: Clinical Trial Service
Table 52. Eli Lilly and Company: Breakdown of Revenue by Therapeutic Area
Table 53. Eli Lilly and Company: Breakdown of Revenue by Region
Table 54. F. Hoffmann-La Roche: Company Snapshot
Table 55. F. Hoffmann-La Roche: Clinical Trial Service
Table 56. F. Hoffmann-La Roche: Business Segmentation
Table 57. F. Hoffmann-La Roche: Revenue by Region
Table 58. ICON Plc: Company Snapshot
Table 59. ICON Plc: Business Segmentation
Table 60. ICON Plc: Product Portfolio
Table 61. ICON Plc: Revenue by Region, 2020, %
Table 62. IQVIA Holdings Inc.: Company Snapshot
Table 63. IQVIA Holdings Inc.: Business Segmentation
Table 64. IQVIA Holdings Inc.: Revenue by Region, 2020, %
Table 65. IQVIA Holdings Inc.: Product Portfolio
Table 66. Covance Inc.: Company Snapshot
Table 67. Covance Inc.: Product Portfolio
Table 68. Covance Inc.: Revenue by Region, 2020, %
Table 69. Novo Nordisk: Company Snapshot
Table 70. Novo Nordisk: Product Portfolio
Table 71. Novo Nordisk: Breakdown of Revenue by Business Segment
Table 72. Novo Nordisk: Breakdown of Revenue by Region
Table 73. PAREXEL International Corporation: Company Snapshot
Table 74. PAREXEL International Corporation: Business Segmentation
Table 75. PAREXEL International Corporation: Revenue by Region, 2018, %
Table 76. PAREXEL International Corporation: Product Portfolio
Table 77. Pfizer Inc.: Company Snapshot
Table 78. Pfizer Inc.: Business Segmentation
Table 79. Pfizer Inc.: Breakdown of Revenue by Product Category
Table 80. Pfizer Inc.: Breakdown of Revenue by Region
Table 81. Pfizer Inc.: Product Portfolio
Table 82. Pfizer Inc.: Revenue, 2018-2020, $ bn
Table 83. Pharmaceutical Product Development LLC (PPD): Company Snapshot
Table 84. Pharmaceutical Product Development LLC (PPD): Breakdown of Revenue by Division
Table 85. Pharmaceutical Product Development LLC (PPD): Breakdown of Revenue by Region
Table 86. Phlexglobal: Company Snapshot
Table 87. PRA Health Sciences Inc.: Company Snapshot
Table 88. PRA Health Sciences Inc.: Business Segmentation
Table 89. PRA Health Sciences Inc.: Revenue by Region, 2018, %
Table 90. Sanofi: Company Snapshot
Table 91. Sanofi: Business Segmentation
Table 92. Sanofi: Breakdown of Revenue by Region
Table 93. SGS SA (SGS Life Sciences): Company Snapshot
Table 94. SGS SA (SGS Life Sciences): Business Segmentation
Table 95. SGS SA (SGS Life Sciences): Revenue by Region, 2018, %
Table 96. Syneos Health Inc.: Company Snapshot
Table 97. Syneos Health Inc.: Business Segmentation
Table 98. Syneos Health Inc.: Revenue by Region, 2020, %
Table 99. WuXi AppTec Inc.: Company Snapshot

List Of Figures

LIST OF FIGURES:

Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2031
Figure 4. Europe Clinical Trials Market, 2021-2031, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of Europe Clinical Trials Market
Figure 7. Percentage of Trial Participants by Country, 2015-2019
Figure 8. Leading Causes of Death in the World, 2000 and 2019, million
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060
Figure 11. Primary Restraints and Impact Factors of Europe Clinical Trials Market
Figure 12. Investment Opportunity Analysis
Figure 13. Porter’s Fiver Forces Analysis of Europe Clinical Trials Market
Figure 14. Breakdown of Europe Clinical Trials Market by Product Category, 2021-2031, % of Revenue
Figure 15. Europe Addressable Market Cap in 2023-2031 by Product Category, Value ($ mn) and Share (%)
Figure 16. Europe Clinical Trials Market by Product Category: Trials of Drugs, 2021-2031, $ mn
Figure 17. Europe Clinical Trials Market by Trials of Drugs: Small Molecule Drugs, 2021-2031, $ mn
Figure 18. Europe Clinical Trials Market by Trials of Drugs: Vaccines, 2021-2031, $ mn
Figure 19. Europe Clinical Trials Market by Trials of Drugs: Cell & Gene Therapy, 2021-2031, $ mn
Figure 20. Europe Clinical Trials Market by Trials of Drugs: Other Drugs, 2021-2031, $ mn
Figure 21. Europe Clinical Trials Market by Product Category: Trials of Devices, 2021-2031, $ mn
Figure 22. Europe Clinical Trials Market by Product Category: Trials of Procedures, 2021-2031, $ mn
Figure 23. Breakdown of Europe Clinical Trials Market by Phase, 2021-2031, % of Sales Revenue
Figure 24. Europe Addressable Market Cap in 2023-2031 by Phase, Value ($ mn) and Share (%)
Figure 25. Europe Clinical Trials Market by Phase: Phase I, 2021-2031, $ mn
Figure 26. Europe Clinical Trials Market by Phase: Phase II, 2021-2031, $ mn
Figure 27. Europe Clinical Trials Market by Phase: Phase III, 2021-2031, $ mn
Figure 28. Europe Clinical Trials Market by Phase: Phase IV, 2021-2031, $ mn
Figure 29. Breakdown of Europe Clinical Trials Market by Design, 2021-2031, % of Sales Revenue
Figure 30. Europe Addressable Market Cap in 2023-2031 by Design, Value ($ mn) and Share (%)
Figure 31. Europe Clinical Trials Market by Design: Interventional Studies, 2021-2031, $ mn
Figure 32. Europe Clinical Trials Market by Interventional Studies: Randomized Control Trial, 2021-2031, $ mn
Figure 33. Europe Clinical Trials Market by Interventional Studies: Adaptive Clinical Trial, 2021-2031, $ mn
Figure 34. Europe Clinical Trials Market by Interventional Studies: Non-randomized Control Trial, 2021-2031, $ mn
Figure 35. Europe Clinical Trials Market by Design: Observational Studies, 2021-2031, $ mn
Figure 36. Europe Clinical Trials Market by Observational Studies: Cohort Study, 2021-2031, $ mn
Figure 37. Europe Clinical Trials Market by Observational Studies: Case Control Study, 2021-2031, $ mn
Figure 38. Europe Clinical Trials Market by Observational Studies: Cross Sectional Study, 2021-2031, $ mn
Figure 39. Europe Clinical Trials Market by Observational Studies: Ecological Study, 2021-2031, $ mn
Figure 40. Europe Clinical Trials Market by Design: Expanded Access Trials, 2021-2031, $ mn
Figure 41. Breakdown of Europe Clinical Trials Market by Service Type, 2021-2031, % of Revenue
Figure 42. Europe Addressable Market Cap in 2023-2031 by Service Type, Value ($ mn) and Share (%)
Figure 43. Europe Clinical Trials Market by Service Type: Protocol Designing, 2021-2031, $ mn
Figure 44. Europe Clinical Trials Market by Service Type: Site Identification, 2021-2031, $ mn
Figure 45. Europe Clinical Trials Market by Service Type: Patient Recruitment, 2021-2031, $ mn
Figure 46. Europe Clinical Trials Market by Service Type: Laboratory Services, 2021-2031, $ mn
Figure 47. Europe Clinical Trials Market by Service Type: Bioanalytical Testing Services, 2021-2031, $ mn
Figure 48. Europe Clinical Trials Market by Service Type: Clinical Trial Data Management Services, 2021-2031, $ mn
Figure 49. Europe Clinical Trials Market by Service Type: Clinical Trial Supply & Logistic Services, 2021-2031, $ mn
Figure 50. Europe Clinical Trials Market by Service Type: Decentralized Clinical Trial Services, 2021-2031, $ mn
Figure 51. Europe Clinical Trials Market by Service Type: Medical Device Testing Services, 2021-2031, $ mn
Figure 52. Europe Clinical Trials Market by Service Type: Other Clinical Trial Services, 2021-2031, $ mn
Figure 53. Breakdown of Europe Clinical Trials Market by Indication, 2021-2031, % of Revenue
Figure 54. Europe Addressable Market Cap in 2023-2031 by Indication, Value ($ mn) and Share (%)
Figure 55. Europe Clinical Trials Market by Indication: Oncology, 2021-2031, $ mn
Figure 56. Europe Clinical Trials Market by Indication: Infectious Diseases, 2021-2031, $ mn
Figure 57. Europe Clinical Trials Market by Indication: Cardiology, 2021-2031, $ mn
Figure 58. Europe Clinical Trials Market by Indication: Obesity, 2021-2031, $ mn
Figure 59. Europe Clinical Trials Market by Indication: Diabetes, 2021-2031, $ mn
Figure 60. Europe Clinical Trials Market by Indication: Neurology, 2021-2031, $ mn
Figure 61. Europe Clinical Trials Market by Indication: Immunology, 2021-2031, $ mn
Figure 62. Europe Clinical Trials Market by Indication: Pain Management, 2021-2031, $ mn
Figure 63. Europe Clinical Trials Market by Indication: Other Indications, 2021-2031, $ mn
Figure 64. Breakdown of Europe Clinical Trials Market by End User, 2021-2031, % of Revenue
Figure 65. Europe Addressable Market Cap in 2023-2031 by End User, Value ($ mn) and Share (%)
Figure 66. Europe Clinical Trials Market by End User: Pharmaceutical and Biotechnological Companies, 2021-2031, $ mn
Figure 67. Europe Clinical Trials Market by End User: Clinical Research Organizations, 2021-2031, $ mn
Figure 68. Europe Clinical Trials Market by End User: Clinical Testing Laboratories, 2021-2031, $ mn
Figure 69. Europe Clinical Trials Market by End User: Other End Users, 2021-2031, $ mn
Figure 70. Breakdown of European Clinical Trials Market by Country, 2022 and 2031, % of Revenue
Figure 71. Contribution to Europe 2023-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 72. Clinical Trials Market in Germany, 2021-2031, $ mn
Figure 73. Clinical Trials Market in U.K., 2021-2031, $ mn
Figure 74. Clinical Trials Market in France, 2021-2031, $ mn
Figure 75. Clinical Trials Market in Spain, 2021-2031, $ mn
Figure 76. Clinical Trials Market in Italy, 2021-2031, $ mn
Figure 77. Clinical Trials Market in Russia, 2021-2031, $ mn
Figure 78. Clinical Trials Market in Rest of Europe, 2021-2031, $ mn
Figure 79. Growth Stage of Europe Clinical Trials Industry over the Forecast Period